Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
7.930
USD
+0.290 (+3.80%)
Official Closing Price
Updated: 7:55 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Applied Dna Scns
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Thinking about buying stock in Greenlane Holdings, vTv Therapeutics, Evolus Inc, Applied DNA Sciences, or Mogo Inc?
March 03, 2021
InvestorsObserver issues critical PriceWatch Alerts for GNLN, VTVT, EOLS, APDN, and MOGO.
From
PR Newswire
Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA™ COVID-19 Vaccine Candidate for Feline Veterinary Market
March 02, 2021
If the veterinary vaccine candidate demonstrates effectiveness, the two companies intend to apply to USDA to enable commercial vet sales under APHIS.
From
Business Wire News Releases
Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
February 25, 2021
Newly granted patent has applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients.
From
Business Wire News Releases
Thinking about buying stock in Vascular Biogenics, Oncolytics Biotech, Protalix Biotherapeutics, AMC Entertainment, or Applied DNA Sciences?
February 23, 2021
InvestorsObserver issues critical PriceWatch Alerts for VBLT, ONCY, PLX, AMC, and APDN.
From
PR Newswire
Applied DNA to Provide Back-To-Campus COVID-19 Surveillance Testing to LIM College
February 19, 2021
NYC-based LIM College joins other education institutions relying on Applied DNA's safeCircle service to ensure a safe learning environment.
From
Business Wire News Releases
Applied DNA Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range
February 11, 2021
Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range
From
Business Wire News Releases
Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
February 11, 2021
Linea(TM) COVID-19 Assay Kit utilized in genomic surveillance mode detects first instance of SARS-CoV-2 B.1.1.7 (UK) variant in Kansas.
From
Business Wire News Releases
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
February 05, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market close on Thursday, February 11, 2021. The Company’s management...
From
Business Wire News Releases
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
February 02, 2021
"Our veterinary vaccine program is a cost- and time-efficient path to commercializing our COVID-19 vaccine development work."
From
Business Wire News Releases
InvestorNewsBreaks – Applied DNA Sciences Inc. (NASDAQ: APDN) Has Closed Registered Direct Offering Resulting in $15M
January 29, 2021
From
InvestorBrandNetwork
Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution
January 26, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace...
From
Business Wire News Releases
Applied DNA Promotes Judith Murrah to Chief Operating Officer
January 20, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah...
From
Business Wire News Releases
Thinking about buying stock in Gevo, Applied DNA Sciences, Surface Oncology, Aldeyra Therapeutics, or BioNano Genomics?
January 19, 2021
InvestorsObserver issues critical PriceWatch Alerts for GEVO, APDN, SURF, ALDX, and BNGO.
From
PR Newswire
Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing
January 19, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™ COVID-19 Assay Kit (the “Assay Kit”)...
From
Business Wire News Releases
Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?
January 15, 2021
InvestorsObserver issues critical PriceWatch Alerts for VBIV, SENS, AMTX, APDN, and APHA.
From
PR Newswire
Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing
January 15, 2021
Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its safeCircle™ pooled surveillance testing service...
From
Business Wire News Releases
Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 13, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct...
From
Business Wire News Releases
Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 11, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has entered into a securities purchase agreement...
From
Business Wire News Releases
U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)
January 08, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that the U.S. Food and Drug Administration (FDA)...
From
Business Wire News Releases
Applied DNA to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
January 05, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that Dr. James A. Hayward, president and CEO, will participate...
From
Business Wire News Releases
Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
January 04, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it expects revenues for the first...
From
Business Wire News Releases
Applied DNA Partners with CLEARED4 on Pooled COVID-19 Surveillance Testing Program
December 29, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that its wholly-owned subsidiary,...
From
Business Wire News Releases
Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results
December 17, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the...
From
Business Wire News Releases
Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government
December 17, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its wholly-owned subsidiary,...
From
Business Wire News Releases
Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
December 11, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its Applied DNA Clinical Laboratories,...
From
Business Wire News Releases
Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST
December 08, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it will release financial results...
From
Business Wire News Releases
Nutrition21 Transitions to Applied DNA’s CertainT® Platform to Secure IP-protected Portfolio of Dietary Supplement Ingredients
December 07, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the expansion of commercial activities...
From
Business Wire News Releases
Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
December 01, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its wholly-owned subsidiary, Applied DNA...
From
Business Wire News Releases
Applied DNA, EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate
November 30, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, EvviVax, S.R.L. (“EvviVax”), a spin-off of Takis Biotech...
From
Business Wire News Releases
Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3
November 27, 2020
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.